|
Dextromethorphan and Donepezil Hydrochloride for Rett Syndrome Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Dextromethorphan and Donepezil Hydrochloride for Rett Syndrome conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Dextromethorphan and Donepezil Hydrochloride for Rett Syndrome Clinical research trials and Dextromethorphan and Donepezil Hydrochloride for Rett Syndrome healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Dextromethorphan and Donepezil Hydrochloride for Rett Syndrome. Dextromethorphan and Donepezil Hydrochloride for Rett Syndrome Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Dextromethorphan and Donepezil Hydrochloride for Rett Syndrome clinical trial. Subjects frequently obtain the most expert healthcare possible for their Dextromethorphan and Donepezil Hydrochloride for Rett Syndrome condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "D" Clinical Trials Conditions > Dextromethorphan and Donepezil Hydrochloride for Rett Syndrome  Dextromethorphan and Donepezil Hydrochloride for Rett Syndrome
Dextromethorphan and Donepezil Hydrochloride for Rett Syndrome
For Condition: Rett Syndrome
Status: Not yet recruiting
Sponsor(s): National Institute of Child Health and Human Development (NICHD) ,
Synopsis: Rett syndrome (RTT) is a disorder in which the nervous system does not develop properly. RTT generally affects girls, but there are some boys who have been diagnosed with RTT. Symptoms of RTT include small brain size, poor language skills, repetitive hand movements, and seizures. This study will evaluate the effectiveness of two drugs in treating the symptoms of RTT.
Details: RTT is a neurodevelopmental disorder characterized by apparently normal early development followed by loss of purposeful hand use, distinctive hand stereotypies, slowed brain growth, loss of language, respiratory irregularities, GI disturbances, gait abnormalities, seizures, and mental retardation. These symptoms appear between ages 6 and 18 months (stage 2 of the disease) following apparently normal development (stage 1). Subsequently, there is gradual stabilization of severe mental retardation and motor compromise (stage 3). The majority (70% to 80%) of patients demonstrate mutations in the methyl-CpG-binding-protein-2 (MeCP2) gene, a transcription repressor located on chromosome Xq28. The disorder predominantly affects females, but a few males with mutations in MeCP2 have been identified, even though many of them do not have the classic symptoms recognized in females. Recent studies demonstrate increased brain N-methyl-D-aspartate (NMDA) receptors in stages 2 and 3 of the disease. This age-specific increase in glutamate levels and their receptors contribute to brain damage. This study will examine the effectiveness of dextromethorphan, an NMDA receptor antagonist, to ameliorate symptoms. Participants will be randomized to receive one of three doses of dextromethorphan. All participants will be admitted to the hospital for three days at the beginning of the study. During this hospital stay, participants will undergo physical exam, Dexascan, MRI, EEG, behavioral assessment, laboratory testing, and neuropsychological evaluations. Participants will be have a follow-up 3-day hospital admission after 6 months, which will include similar assessments. Reduction in choline acetyltransferase activity in RTT patients may also contribute to disturbed cortical development and psychomotor retardation in RTT. Therefore, the study will also evaluate the effect of donepezil hydrochloride, an inhibitor of acetylcholine-esterase, on acetylcholine levels. This portion of the study will not begin until pharmacokinetic data for donepezil in children is available.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Open Label, Dose Comparison, Factorial Assignment, Efficacy Study
Minimum Age/Maximum Age: 1 Year/15 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria - Diagnosis of Rett syndrome - Mutation in MeCP2 gene - Typical EEG abnormalities (disorganized background, frontal central spikes, rhythmic theta) Exclusion Criteria - Features of Rett syndrome with absence of MeCP2 mutation - Non-specific EEG changes
Total Enrollment: 90
Location and Contact Information:
Overall Study Official:
SakkuBaiNaidu, Principal Investigator, Kennedy Krieger Research Institute
Kennedy Krieger Institute
Baltimore, Maryland,
United States
SakkuBai Naidu 443-923-2778
Additional Information:
Study ID Numbers: HD024448; 5 PO1 HD024448
Study Start Date:
Record last reviewed: September 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00069550
Other Rett Syndrome Studies:
1. Study of Cardiac and Paroxysmal Abnormalities in Rett Syndrome
2. Dextromethorphan and Donepezil Hydrochloride for Rett Syndrome
3. Nutritional Aspects of Rett Syndrome
4. Study of the Pathogenesis of Rett Syndrome
Related Studies:
Other Rett Syndrome Clinical Trials
Other Maryland Clinical Trials
Other Baltimore Clinical Trials
Dextromethorphan and Donepezil Hydrochloride for Rett Syndrome
|
|
|
|
|
|
|
|
